| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Robinson Chandler is a Chief Executive Officer at Monopar Therapeutics. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $5.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | MNPR Monopar Therapeutics | Chief Executive Officer | Sell | 16,800 | $40.00 | $672,020.16 | -18.6% | +133.4% | - |